108 related articles for article (PubMed ID: 11018748)
21. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
DeStephano DB; Lloyd RV; Pike AM; Wilson BS
Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin receptor profile in pituitary thyrotroph adenomas.
Thodou E; Kontogeorgos G
Clin Neurol Neurosurg; 2020 Aug; 195():105865. PubMed ID: 32416325
[TBL] [Abstract][Full Text] [Related]
23. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
24. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
25. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
26. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
[TBL] [Abstract][Full Text] [Related]
27. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
[TBL] [Abstract][Full Text] [Related]
28. Messenger ribonucleic acid expression of platelet-derived growth factor subunits and receptors in pituitary adenomas.
Leon SP; Carroll RS; Dashner K; Glowacka D; Black PM
J Clin Endocrinol Metab; 1994 Jul; 79(1):51-5. PubMed ID: 8027252
[TBL] [Abstract][Full Text] [Related]
29. Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor.
Lalli E; Sassone-Corsi P
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9633-7. PubMed ID: 7568187
[TBL] [Abstract][Full Text] [Related]
30. Presence of ghrelin in normal and adenomatous human pituitary.
Korbonits M; Kojima M; Kangawa K; Grossman AB
Endocrine; 2001 Feb; 14(1):101-4. PubMed ID: 11322490
[TBL] [Abstract][Full Text] [Related]
31. Regulation of pituitary thyrotropin gene expression during Xenopus metamorphosis: negative feedback is functional throughout metamorphosis.
Manzon RG; Denver RJ
J Endocrinol; 2004 Aug; 182(2):273-85. PubMed ID: 15283688
[TBL] [Abstract][Full Text] [Related]
32. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas.
Dieterich KD; Gundelfinger ED; Lüdecke DK; Lehnert H
J Clin Endocrinol Metab; 1998 Sep; 83(9):3327-31. PubMed ID: 9745449
[TBL] [Abstract][Full Text] [Related]
33. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
35. Functional thyrotropin receptor expression in the pituitary folliculo-stellate cell line TtT/GF.
Brokken LJ; Bakker O; Wiersinga WM; Prummel MF
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):13-20. PubMed ID: 15662590
[TBL] [Abstract][Full Text] [Related]
36. Decreased anterior pituitary T3 nuclear receptors in a Walker 256 carcinoma-bearing rat model of nonthyroidal disease.
Hupart KH; DeFesi CR; Katz CP; Shapiro LE; Surks MI
Acta Endocrinol (Copenh); 1989 Dec; 121(6):811-6. PubMed ID: 2609901
[TBL] [Abstract][Full Text] [Related]
37. Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence.
Kirkman MA; Jaunmuktane Z; Brandner S; Khan AA; Powell M; Baldeweg SE
World Neurosurg; 2014 Dec; 82(6):1224-31. PubMed ID: 24657816
[TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas.
Oka H; Jin L; Reubi JC; Qian X; Scheithauer BW; Fujii K; Kameya T; Lloyd RV
Am J Pathol; 1998 Dec; 153(6):1787-96. PubMed ID: 9846969
[TBL] [Abstract][Full Text] [Related]
39. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
40. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
Sanno N; Teramoto A; Matsuno A; Osamura RY
Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
